Clinical Trials
5 trialsNCT07219212 2026-05-08
LUMIRAY
Johnson & Johnson Enterprise Innovation Inc.
Phase 1 Recruiting
NCT02937272 2026-04-03
A Study of LY3200882 in Participants With Solid Tumors
Eli Lilly and Company
Phase 1 Active not recruiting
NCT06056310 2025-09-29
Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)
EMD Serono
Phase 1 Terminated
NCT06011291 2023-10-27
A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT02555644 2019-02-15
A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer
Eli Lilly and Company
Phase 1 Completed